The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: -2.00 (-4.60%)
Spread: 1.00 (2.439%)
Open: 43.50
High: 43.50
Low: 41.50
Prev. Close: 43.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Celerum appoints David Gladding as CEO

9 Jan 2023 07:00

RNS Number : 9966L
Frontier IP Group plc
09 January 2023
 

Reach - a non-regulatory announcement

AIM: FIPP

9 January 2023

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Celerum appoints David Gladding as Chief Executive Officer

 

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Celerum Limited ("Celerum" or the "Company") has appointed David Gladding as Chief Executive Officer.

 

His experience in the software industry will help drive both the commercial and technical development of the Company's novel artificial intelligence-based metaheuristics, including nature inspired computing ("NIC"), to make logistics more efficient.

 

Celerum is at an important stage of development. The Company launched its first commercial product, Truck Logistics System (TLS), earlier this year to cut road haulage costs, carbon emissions and delivery times for small to medium-sized truck fleets, which is now winning customers. The first was Colin Lawson Transport, a haulage firm based in Aberdeen, operating 75 trucks and about 150 trailers. Frontier IP holds a 33.8 per cent equity stake in the Company.

David has more than 30 years' experience at senior levels in software and IT services companies, including those specialising in fleet management. He was Senior Vice President Global Sales for Chevin Fleet Solutions and has also worked for Civica and Fleet Clear over the past 12 years gaining a wide and in-depth understanding of the industry.

 

Other potential applications for the technology are in the maritime, energy, and telecommunication sectors where positive use cases have already been identified.

 

The technology is based on more than 25 years' research into metaheuristics by Celerum founder and chair Professor John McCall, Head of the School of Computing, Science and Digital Media at Robert Gordon University, Aberdeen. He is a director of the Company and continues to support development of the software.

 

Metaheuristic algorithms lie at the heart of Celerum's technology. They are designed to find the best solution out of a range of possible solutions to particularly complex problems. A subset of these is NIC algorithms, which use lessons from the natural world where evolution has overcome inefficiency. For example, bees and ants are extremely good at finding the best routes to food sources or returning to their nests.

 

Researchers have found metaheuristic algorithms achieve a high degree of accuracy when used to predict and propose "what if" scenarios, providing a basis to explore. This formed the basis to explore industry applications.

 

Unlike other forms of AI, such as machine learning, algorithms based on metaheuristics do not need to be trained on past data or special training datasets, helping to make Celerum's software easy to deploy. It needs no special hardware and resides in the cloud to give customers access to an evolving platform. Celerum's AI works as soon as it is activated to enable customers to take advantage of opportunities sooner than most other systems.

Celerum Chief Executive Officer David Gladding said: "I am excited to be joining Celerum at this time. We have an opportunity to help businesses understand what their data is telling them, giving them easy access to very smart technology that will help simplify complex business challenges. The real power behind our AI is how it helps educate users when interrogating data to increase their success of making informed business decisions. Whilst our platform is industry agnostic, we have won customers from the fleet management industry, which is worth $27 billion a year globally. Our platform is unique in this market, and I am expecting to see a great deal of interest. We know that this market is intensely competitive, where every marginal gain is important, and we believe our software can give customers an important edge in efficiency and productivity gains, cutting costs and making their operations greener."

Professor John McCall, Head of the School of Computing, Science and Digital Media at Robert Gordon University, Aberdeen, and Celerum director said: "David has a very keen interest in how we use data to improve business efficiencies and reducing the carbon footprint, along with his vast experience in software and the fleet industry, we are excited that David is leading Celerum to future success".

Neil Crabb, Frontier IP Chief Executive Officer, said: "I am delighted with David's appointment as Celerum's Chief Executive. His experience means he is the right person to drive the Company forward following the successful launch of its first commercial product."

 

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive Officer

Andrew Johnson, Communications and investor relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

 

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

 

ABOUT METAHEURISTICS

Metaheuristics are a development of heuristics: a heuristic is a cognitive short cut used by humans and computers to arrive at a decision or solution in the face of confusing and sometimes conflicting data.

Metaheuristic algorithms are designed to derive the best possible solutions to complex problems where there are no perfect answers. These problems could involve incomplete or imperfect data, unpredictability, tight timeframes, unpredictability, and limited computing power.

There are many different strategies used to develop metaheuristic algorithms. They include local search, where an existing, single solution is refined to develop an optimal answer; global search, where several solutions are collectively refined to solve a problem in the best way; and nature inspired computing, where lessons from the natural world are applied.

An algorithm based on the theory of evolution, for example, will test many potential answers until the "fittest" emerges.

Often different metaheuristic approaches are combined - a development known as hybrid metaheuristics. They can be applied to many different problems. Unlike other forms of artificial intelligence, such as machine learning, metaheuristics do not have to be trained on large datasets.

Celerum has applied these methodologies and developed bespoke algorithms specifically for logistic companies to help them tackle the complexity of managing many trucks and drivers. Many firms currently rely on multiple legacy systems.

Because of the way metaheuristics work, they are very efficient in terms of the amount of data they process. Metaheuristic algorithms do not need to be trained on large datasets. Therefore, they provide a very cost-effective way to reach an intelligent solution that would otherwise be out of reach for many small to medium size logistic businesses. The algorithms are able to work on everyday computers, mobile phones and other devices.

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQQLFBXFLXBBE
Date   Source Headline
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.